SLC25A11
Mitochondrial 2-oxoglutarate/malate carrier protein
Also known as: M2OM_HUMAN, OGC, SLC20A4
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q02978
- Gene
- SLC25A11
- Ensembl
- ENSG00000108528
- Chromosome
- 17
- Canonical length
- 314 aa
- Protein class
- Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters
OverviewNCBI Gene
The oxoglutarate/malate carrier transports 2-oxoglutarate across the inner membranes of mitochondria in an electroneutral exchange for malate or other dicarboxylic acids (summary by Iacobazzi et al., 1992 [PubMed 1457818]).[supplied by OMIM, Jan 2011]
Canonical amino-acid sequenceUniProt
314 residues, UniProt reviewed canonical sequence.
>Q02978|SLC25A11
1 MAATASAGAG GIDGKPRTSP KSVKFLFGGL AGMGATVFVQ PLDLVKNRMQ LSGEGAKTRE
61 YKTSFHALTS ILKAEGLRGI YTGLSAGLLR QATYTTTRLG IYTVLFERLT GADGTPPGFL
121 LKAVIGMTAG ATGAFVGTPA EVALIRMTAD GRLPADQRRG YKNVFNALIR ITREEGVLTL
181 WRGCIPTMAR AVVVNAAQLA SYSQSKQFLL DSGYFSDNIL CHFCASMISG LVTTAASMPV
241 DIAKTRIQNM RMIDGKPEYK NGLDVLFKVV RYEGFFSLWK GFTPYYARLG PHTVLTFIFL
301 EQMNKAYKRL FLSGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLC25A11 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 6
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 420 nTPM
Expression across tissuesHPA
Tissue
- tongue: 420 nTPM
- skeletal muscle: 295 nTPM
- heart muscle: 219 nTPM
- choroid plexus: 78 nTPM
- cerebral cortex: 73 nTPM
- kidney: 69 nTPM
Single-cell type
- extravillous trophoblasts: 167 nCPM
- cytotrophoblasts: 155 nCPM
- migrating cytotrophoblasts: 136 nCPM
- esophageal basal cells: 129 nCPM
- tuft cells: 127 nCPM
- hofbauer cells: 118 nCPM
Immune cell
- total PBMC: 186 nTPM
- intermediate monocyte: 177 nTPM
- classical monocyte: 171 nTPM
- non-classical monocyte: 166 nTPM
- myeloid DC: 161 nTPM
- NK-cell: 152 nTPM
Brain region
- cerebellum: 79 nTPM
- thalamus: 77 nTPM
- hippocampal formation: 77 nTPM
- hypothalamus: 71 nTPM
- midbrain: 69 nTPM
- cerebral cortex: 66 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SLC25A11.
Disease | AllUniProt
Conditions SLC25A11 is implicated in, by any mechanism.
- Pheochromocytoma/paraganglioma syndrome 6 (PPGL6) MIM:618464
Disease | GeneticClinVar
5 pathogenic / likely-pathogenic of 93 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Pheochromocytoma/paraganglioma syndrome 6
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.51
- gnomAD pLI
- 0.53
- gnomAD missense Z
- 2.49
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- RNA binding
- transmembrane transporter activity
- oxoglutarate:malate antiporter activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SLC25A11 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLC25A11 as an antibody target. Whether an autoantibody or antibody against SLC25A11 could matter depends on whether native SLC25A11 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLC25A11 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SLC25A11 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...